-
Ginkgo Bioworks partners with Invaio Sciences on peptide manufacturing
-
Ginkgo Bioworks lab reduces protein synthesis costs 40% using GPT-5
-
Ginkgo Bioworks shifts operating duties in leadership restructure
-
Ginkgo Bioworks partners with Carnegie Mellon for cancer screening project
-
Ginkgo Bioworks completes collaboration with Agricen on fermentation process
-
Ginkgo Bioworks joins ARPA-H funded drug safety prediction project
-
Ginkgo Bioworks wins $47M DOE contract for automated lab platform
-
Ginkgo Bioworks receives $22.2 million BARDA contract for filovirus antibody work
-
Ginkgo Bioworks settles shareholder derivative lawsuits for $4.1 million
-
Ginkgo Bioworks Holdings Inc (DNA) PT Raised to $9 at BTIG
-
Ginkgo Bioworks partners with Inductive Bio and Tangible Scientific for drug discovery
-
Ginkgo Automation names Brian O'Sullivan head of commercial
-
Ginkgo Bioworks Holdings Inc (DNA) PT Raised to $16 at TD Cowen
-
Ginkgo Bioworks wins $4.66M contract with Pacific Northwest National Laboratory
-
Ginkgo Bioworks launches ADME profiling service with price matching
-
Ginkgo Bioworks (DNA) appoints Steven Coen as CFO
-
Twist Bioscience Corporation (TWST) and Ginkgo Bioworks (DNA) Revise Collaboration
-
Ginkgo Bioworks (DNA) Misses Q1 EPS by 168c
-
Ginkgo Bioworks (DNA) Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain
-
Ginkgo Bioworks (DNA) integrates Callisto
-
Ginkgo Bioworks (DNA) Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors
-
Ginkgo Bioworks (DNA) Awarded $9.4M in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices
-
Ginkgo Bioworks Holdings Inc (DNA) PT Raised to $10 at TD Cowen
-
Ginkgo Bioworks (DNA) Launches Ginkgo Datapoints
-
TD Cowen Reiterates Buy Rating on Ginkgo Bioworks Holdings Inc (DNA)
-
Ginkgo Bioworks (DNA) Regains NYSE Compliance
-
Ginkgo Bioworks Holdings Inc (DNA) PT Raised to $7 at BTIG
-
Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $7 at Goldman Sachs
-
BTIG Reiterates Sell Rating on Ginkgo Bioworks Holdings Inc (DNA)
-
Ginkgo Bioworks (DNA) Misses Q2 EPS by 3c, provides guidance
-
Syngenta collaborates with Ginkgo Bioworks (DNA) to enable faster launch of innovative biologicals
-
Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $0.20 at BTIG

